Perceptive Advisors - AEGLEA BIOTHERAPEUTICS INC ownership

AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 28 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
Perceptive Advisors ownership history of AEGLEA BIOTHERAPEUTICS INC
ValueSharesWeighting
Q2 2018$272,000
+532.6%
25,694
+340.5%
0.01%
+250.0%
Q1 2017$43,000
-90.5%
5,833
-94.4%
0.00%
-93.8%
Q4 2016$451,000
-32.1%
103,5850.0%0.03%
-25.6%
Q3 2016$664,000
+28.9%
103,585
-2.2%
0.04%
+19.4%
Q2 2016$515,000105,8930.04%
Other shareholders
AEGLEA BIOTHERAPEUTICS INC shareholders Q3 2016
NameSharesValueWeighting ↓
Yu Fan 112,044$258,0003.49%
Aisling Capital Management LP 1,691,151$3,890,0002.10%
Sio Capital Management, LLC 871,101$2,004,0000.66%
Bain Capital Life Sciences Investors, LLC 2,847,689$6,550,0000.64%
Samsara BioCapital, LLC 883,720$2,033,0000.51%
Ghost Tree Capital, LLC 686,599$1,579,0000.34%
Nantahala Capital Management 3,200,593$7,361,0000.33%
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO 245,678$565,0000.29%
SUVRETTA CAPITAL MANAGEMENT, LLC 4,059,894$9,338,0000.28%
Lion Point Capital, LP 300,000$690,0000.16%
View complete list of AEGLEA BIOTHERAPEUTICS INC shareholders